BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang BY, Lu Y, Dong Q, Sun CD, Mu P. Surgical treatment and prognostic analysis of 93 cases of hilar cholangiocarcinoma. Am J Med Sci 2010;339:221-4. [PMID: 20220331 DOI: 10.1097/MAJ.0b013e3181c7c8b4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Tan XY, Chang S, Liu W, Tang HH. Silencing of CXCR4 inhibits tumor cell proliferation and neural invasion in human hilar cholangiocarcinoma. Gut Liver 2014;8:196-204. [PMID: 24672662 DOI: 10.5009/gnl.2014.8.2.196] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
2 Zhao J, Zhang W, Zhang J, Ma WJ, Liu SY, Li FY, Song B. External validation study of the 8th edition of the American Joint Committee on Cancer staging system for perihilar cholangiocarcinoma: a single-center experience in China and proposal for simplification. J Gastrointest Oncol 2021;12:806-18. [PMID: 34012668 DOI: 10.21037/jgo-20-348] [Reference Citation Analysis]
3 Yu Z, Zhu J, Jiang H, He C, Xiao Z, Wang J, Xu J. Surgical Resection and Prognostic Analysis of 142 Cases of Hilar Cholangiocarcinoma. Indian J Surg 2018;80:309-17. [PMID: 32288384 DOI: 10.1007/s12262-016-1581-z] [Reference Citation Analysis]
4 Horgan A, Knox J, Aneja P, Le L, McKeever E, McNamara M. Patterns of care and treatment outcomes in older patients with biliary tract cancer. Oncotarget 2015;6:44995-5004. [PMID: 26575326 DOI: 10.18632/oncotarget.5707] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]